(Q40878476)

24 September 2017

Sigma ligands inhibit the growth of small cell lung cancer cells (English)

1 reference

24 September 2017

T W Moody

1

1 reference

24 September 2017

J Leyton

series ordinal

2

1 reference

24 September 2017

C John

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

24 September 2017

1 reference

24 September 2017

66

1 reference

24 September 2017

20

1 reference

24 September 2017

1979-1986

1 reference

Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Sigma receptors are expressed in human non-small cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-, and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900523-3

10.1016/S0024-3205(00)00523-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference